【レポートの概要（一部）】
1. Report Overview
1.1 Non-Small Cell Lung Cancer (NSCLC) Overview
1.2 Why You Should Read this Report
1.3 How this Report Delivers
1.4 Main Questions Answered by this Report
1.5 Who is this Report for?
1.6 Research and Analysis Methods
1.7 Frequently Asked Questions (FAQ)
1.8 Some Associated Reports
1.9 About Visiongain
2. Introduction to NSCLC and its Treatment
2.1 Lung Cancer is the Most Common Cancer, and NSCLC Accounts for 85%-90% of All Cases
2.2 The Three Main Histological Sub-Types of NSCLC
2.3 Genetic Mutations Allow for Targeted Therapies
2.4 Staging of NSCLC
2.5 Treatment Protocols by Stage
2.5.1 Stage 1 or 2
2.5.2 Stage 3
2.5.3 Stage 4: First Line-Therapy
2.5.3.1 Standard Chemotherapy Used to be the Only Treatment Option
2.5.3.2 Newer Therapies offers Improved Treatment Outcomes
2.5.3.3 Summary of First-Line Therapy Options: Un-Met Need in Squamous Patient Population
2.5.4 Maintenance Therapy
2.5.5 Second-Line and Third-Line Therapy
3. Leading NSCLC Drugs, 2015-2025
3.1 Alimta (pemetrexed) by Eli Lilly – The Leading NSCLC Therapy
3.1.1 Mechanism of Action
3.1.2 Three out of its Four FDA-Approved Indications are for NSCLC
3.1.3 Patent Expiries
3.1.3.1 ‘Method-Of-Use’ Vitamin Dosage Regimen Patent – Alimta’s Saviour from Generic Competition?
3.1.4 NICE Rejects Alimta for Maintenance Therapy
3.1.5 Total Alimta Revenues, 2010-2014
3.1.6 Alimta for NSCLC, 2014
3.1.7 Alimta for NSCLC Forecast, 2015-2025
3.2 Avastin (bevacizumab) – Roche’s Cancer Behemoth is a Leading Presence in NSCLC
3.2.1 Mechanism of Action
3.2.2 Multiple Approved Indications, but NSCLC was one of the First
3.2.3 Growing Discontent with Avastin in NSCLC – Is it Cost-Effective?
3.2.4 Total Avastin Revenues, 2010-2014
3.2.5 Avastin for NSCLC Forecast, 2015-2025
3.3 Tarceva (erlotinib) by Roche
3.3.1 Mechanism of Action
3.3.2 Three of Four Indications are for NSCLC
3.3.3 NICE Changes Mind on Tarceva – and then Changes it Back Again
3.3.4 Total Tarceva Revenues, 2010-2014
3.3.5 Tarceva for NSCLC Forecast, 2015-2025
3.4 Iressa (gefitinib) by AstraZeneca
3.4.1 Iressa Finally Returns to the Crucial US Market after Four Year Departure
3.4.2 Iressa NSCLC Revenues, 2010-2014
3.4.3 Iressa for NSCLC Forecast, 2015-2025
3.5 Gilotrif (afatinib) by Boehringer Ingelheim
3.5.1 Newcomer to the Market Rounds out the Trio of Currently Approved EGFR Inhibitors
3.5.2 Gilotrif Displays Significant Survival Benefit over Tarceva in Squamous Setting
3.5.3 Gilotrif for NSCLC Forecast, 2015-2025
3.6 Xalkori (crizotinib) by Pfizer
3.6.1 Mechanism of Action
3.6.2 The First Approved ALK Inhibitor
3.6.3 Co-Promotion with Merck KGaA, and has Treated Over 8,000 Patients
3.6.4 Xalkori NSCLC Revenues, 2012-2014
3.6.5 Xalkori for NSCLC Forecast, 2015-2025
3.7 Abraxane (paclitaxel Protein-Bound) by Celgene
3.7.1 Mechanism of Action
3.7.2 Relatively Recent Approval for NSCLC Indication
3.7.3 Finally Approved for NSCLC in the EU
3.7.4 Total Abraxane Revenues, 2010-2014
3.7.5 Abraxane for NSCLC Forecast, 2015-2025
3.8 Taxotere (docetaxel) by Sanofi
3.8.1 Mechanism of Action and Approved Indications
3.8.2 Sanofi Unable to Prevent Generics, Despite Appeal
3.8.3 Total Taxotere Revenues, 2010-2014
3.8.4 Taxotere for NSCLC Forecast, 2015-2025
3.9 Cyramza (ramucirumab) by Eli Lilly
3.9.1 Mechanism of Action
3.9.2 Many Approvals in Quick Succession
3.9.3 Cyramza for NSCLC Forecast, 2015-2025
3.10 Gemzar (gemcitabine) by Eli Lilly
3.11 Zykadia (ceritinib) by Novartis
3.11.1 Mechanism of Action and Recent Approval
3.11.2 Zykadia for NSCLC Forecast, 2015-2025
3.12 Opdivo (nivolumab) by Bristol-Myers Squibb
3.12.1 Mechanism of Action – Works With the Immune System to Fight Cancers
3.12.2 Swift Approvals through FDA Priority Review Programmes
3.12.3 Good News and Bad News for NSCLC from CheckMate Trials
3.12.4 Opdivo for NSCLC Forecast, 2015-2025
4. NSCLC R&D Pipeline, 2015-2025
4.1 Alecensa (alectinib) by Roche
4.1.1 Japan Becomes First Country to Approve and Launch Alectinib
4.1.2 Roche is Inching Closer Towards the All-Important US Approval
4.1.3 Four Ongoing Clinical Trials involving Alectinib in NSCLC
4.1.4 Japanese Revenues and Future Outlook
4.2 Vargatef (nintedanib) by Boehringer Ingelheim
4.2.1 EU Becomes First Region to Approve Vargatef
4.2.2 NICE has a Change of Heart on Vargatef
4.2.3 Ongoing Clinical Trials Involving Vargatef in NSCLC
4.3 AZD9291 by AstraZeneca
4.3.1 Regulatory Filings in the US and EU, Expected Times for Filings in Japan and China
4.3.2 Collaboration with Roche to Develop Companion Diagnostic
4.3.3 Positive Preliminary Results Presented at ASCO 2015
4.3.4 Ongoing Clinical Trials Involving AZD9291 in NSCLC
4.4 Rociletinib (CO-1686) by Clovis Oncology
4.4.1 In a Race to Approval Against AZD9291
4.4.2 Results So Far Have not Distinguished it Enough from Main Rival
4.4.3 Four Ongoing Clinical Trials Involving Rociletinib in NSCLC
4.5 Keytruda (pembrolizumab) by Merck (MSD)
4.5.1 Has Been Approved for Melanoma, NSCLC is one of the Next Major Targets
4.5.2 Ongoing Clinical Trials Involving Keytruda in NSCLC
4.6 Ganetespib (STA-9090) by Synta Pharmaceuticals
4.6.1 Ganetespib Mechanism of Action
4.6.2 Three Ongoing Clinical Trials Involving Ganetespib in NSCLC
4.7 Halaven (eribulin) by Eisai
4.7.1 Halaven Mechanism of Action
4.7.2 Clinical Trials Involving Halaven in NSCLC
4.8 Necitumumab by Eli Lilly
4.8.1 Phase 3 Results Show Modest Benefits and Worrying Adverse Event Profile
4.8.2 Eli Lilly has Filed for Approval in US and EU, and Verdict is Likely to be Positive, Despite Reservations
4.8.3 Ongoing Clinical Trials Involving Necitumumab in NSCLC
4.9 Atezolizumab (MPDL3280A) by Roche
4.9.1 Mechanism of Action
4.9.2 Atezolizumab Doubles Likelihood of Survival in Certain Subset of Patients
4.9.3 Six Ongoing Clinical Trials Involving Atezolizumab in NSCLC
5. Global NSCLC Market, 2015-2025
5.1 The Global NSCLC Market Forecast, 2015-2025
5.2 What Factors will Drive Growth in the Global NSCLC Market?
5.3 Growing Ageing Population
5.4 The Identification of Biomarkers for Targeted Therapies
5.5 Dynamic and Lucrative Sector with Strong Pipeline
5.6 Satisfying the Large Un-Met Need that is Treatment for Squamous Patients
5.7 What Factors will Restrain Growth in the Global NSCLC Market?
5.8 Patent Expiries and Generic Erosion will be the Main Detriment to the Market
5.9 New Therapies That Reportedly Offer Only Modest Benefits Over Existing Treatments
5.10 Declining Healthcare Budgets lead to Cost Pressures, and Resistance to Therapies is another Issue
5.11 SWOT Analysis of the Global NSCLC Market
6. Leading Therapeutic Segments and National Markets within the Global NSCLC Market
6.1 Therapeutic Composition of the Market in 2015 Compared to 2025
6.1.1 Therapeutic Segments Forecast, 2015-2025
6.1.2 Chemotherapy Segment Forecast, 2015-2025
6.1.3 EGFR and ALK Inhibitors Segment Forecast, 2015-2025
6.1.4 VEGF / VEGFR Inhibitors Segment Forecast, 2015-2025
6.1.5 Immunotherapy Segment Forecast, 2015-2025
6.2 Leading National Markets for NSCLC
6.2.1 Regional Composition of the Global Market in 2015, Compared to 2025
6.2.2 Leading Regional Markets for NSCLC Forecast, 2015-2025
6.2.3 US NSCLC Market, 2015-2025
6.2.3.1 Experiencing Some Changes, but Will Retain Dominance Throughout Forecast Period
6.2.3.2 US NSCLC Market Forecast, 2015-2025
6.2.4 EU5 NSCLC Market, 2015-2025
6.2.4.1 German NSCLC Market: Leader in EU, but Facing Big Reforms
6.2.4.2 German NSCLC Market Forecast, 2015-2025
6.2.4.3 French NSCLC Market: Strong National Healthcare System, Despite Economic Woes
6.2.4.4 French NSCLC Market Forecast, 2015-2025
6.2.4.5 Italian NSCLC Market
6.2.4.6 Italian NSCLC Market Forecast, 2015-2025
6.2.4.7 UK NSCLC Market: Pricing is a Key Issue, Providing Restraints to Revenues
6.2.4.8 UK NSCLC Market Forecast, 2015-2025
6.2.4.9 Spanish NSCLC Market
6.2.4.10 Spanish NSCLC Market Forecast, 2015-2025
6.2.5 Japanese NSCLC Market
6.2.5.1 Expansion of the Generics Market is a Key Factor
6.2.5.2 Japanese NSCLC Market Forecast, 2015-2025
6.2.6 BRIC NSCLC Market, 2015-2025
6.2.6.1 China NSCLC Market: Rapid Growth Will Make it one of the Major Global Players
6.2.6.2 China NSCLC Market Forecast, 2015-2025
6.2.6.3 Brazilian NSCLC Market: Taken Great Strides Forward with Healthcare
6.2.6.4 Brazilian NSCLC Market Forecast, 2015-2025
6.2.6.5 Russian NSCLC Market: Punches Below its Weight
6.2.6.6 Russian NSCLC Market Forecast, 2015-2025
6.2.6.7 Indian NSCLC Market: Generics are King
6.2.6.8 Indian NSCLC Market Forecast, 2015-2025
7. Research Interview
7.1 Interview with Novartis
7.1.1 On the Need for More than one ALK Inhibitor on the Market
7.1.2 Main Trends and Opportunities for NSCLC
7.1.3 The Present and the Future
8. Conclusions from Our Research and Analysis
8.1 How Will Revenues Change over the Forecast Period?
8.2 How will the Therapeutic Composition of the Market Change over the Forecast Period?
8.3 How Will the National Composition of the Global Market Change Over the Forecast Period?
8.4 Concluding Remarks
【レポート販売概要】
■ タイトル：非小細胞肺がん（NSCLC）治療薬の世界市場：市場、企業、研究開発展望■ 英文：Non-Small Cell Lung Cancer Drugs: Market, Companies and R&D Outlook 2015-2025
■ 発行日：2015年10月
■ 調査会社：visiongain
■ 商品コード：VGAIN5112511
■ 調査対象地域：グローバル
- ペンニードル（ペン型注入器用注射針）の世界市場：標準型ペンニードル、安全型ペンニードル、針長別分析、療法別分析Over the years, the pen needles market has witnessed various technological advancements in order to cater to the growing demand of safety injections in the healthcare industry. These advancements have led to development of safety pen needles with an aim to reduce pain, increase comfort, and most importantly reduce needlestick injuries (NSIs). The standard pen needles segment accounts for the large …
- 世界の高純度けい砂市場2015< Global High Purity Quartz Sand Industry 2015 Market Research Report> is a professional and deep research report on Global and China High Purity Quartz Sand industry. For overview analysis, the report introduces High Purity Quartz Sand basic information including definition, classification, application, industry chain structure, industry overview, policy analysis, and news analysis, etc. For inte …
- PDCドリルビットの世界市場：タイプ別（マトリックスボディ、スチールボディ）、PDCカッターのサイズ別（9mm未満、9～14mm、15～24mm、24mm超）、ブレード数別（6未満、6～10、10超）、地域別予測Global PDC drill bits Market to reach USD 5.0 billion by 2025. Global PDC drill bits Market valued approximately USD 3.4 billion in 2016 is anticipated to grow with a healthy growth rate of more than 4.43% over the forecast period 2017-2025. Key factors which give growth to the PDC drill bits market is increase in oil & gas drilling activities around the world matrix body can withstand an impact l …
- UAEの防衛市場動向Summary The Future of the UAE Defense Industry - Market Attractiveness, Competitive Landscape and Forecasts to 2019 published by Strategic Defence Intelligence, provides readers with a detailed analysis of both historic and forecast UAE defense industry values, factors influencing demand, the challenges faced by industry participants, analysis of industry leading companies and key news. Key Findin …
- 工業用鋳物の世界市場2016-2020：鉄系鋳物、非鉄系鋳物About Industrial Castings Metal casting is a manufacturing process in which metal (molten or liquid) is poured into a mold made of sand or ceramic plaster. The mold contains a hollow cavity of the desired shape to form geometrically complex parts. Metal casting finds application in planes, trains, mining, construction, electrical equipment, oil wells, pipes, toys, space shuttles, wind turbines, an …
- 2014年戦略提言：スペインの病院止血診断検査市場This new report from Venture Planning Group contains 390 pages, 28 tables, and presents a comprehensive analysis of the Spanish hospital hemostasis diagnostic testing market, including: Major issues pertaining to the Spanish coagulation laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five yea …
- 試験室用分析機器の世界市場2017-2021About laboratory analytical instrumentsLaboratory analytical instruments are used in research processes to measure, analyze, and verify the unproven quantities, properties, and phenomena of an element or material. Compared with other instruments such as scales and chronometers, these are more specialized and sophisticated in terms of their use. Technavio’s analysts forecast the global laboratory a …
- Venous Leg Ulcers (Crural ulcer)：グローバル臨床試験レビューH1, 2013Venous Leg Ulcers (Crural ulcer) Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, “Venous Leg Ulcers (Crural ulcer) Global Clinical Trials Review, H1, 2013" provides data on the Venous Leg Ulcers (Crural ulcer) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Venous Leg Ulcers (Crural ulcer). It inclu …
- 美容液（セラム）の世界市場2016-2020A cosmetic serum is a product applied externally for a desired cosmetic effect. It is usually a water-based non-greasy and intensive formula that contains a high concentration of active substances. Serums can also be oil and water based but have an oil-free texture (owing to choice and less concentration of oil used in formulation), which helps serums to penetrate deeper. Serums contain high conce …
- ゲーム産業における仮想現実（VR）の世界市場分析：構成要素別、デバイス別（ゲーム機、デスクトップ、スマートフォン）、国別（米国、カナダ、ドイツ、イギリス、中国、インド、日本、ブラジル、メキシコ）、セグメント予測 2014-2025The global virtual reality (VR) in gaming market size is expected to reach USD 45.09 billion by 2025, according to a new report by Grand View Research, Inc. Increasing competitiveness among key players such as Microsoft Corp., Sony Corp., and Nintendo Co. Ltd. to launch VR-compatible consoles has triggered industry growth. Virtual reality technology can enable gamers to indulge in an imaginary set …
- 世界のデータセンター向け精密空調システム市場（2014-2018）About Precision Air Conditioning Precision air conditioning is a cooling solution that is designed to provide efficient and distributed cooling of data center facilities. These solutions are used to maintain the temperature and humidity levels in data center facilities. There has been a rapid increase in the adoption of high-performance computing and data processing solutions in data center facili …
- 世界の商用航空機市場動向2013-2023Why was the report written? “The Global Commercial Aircraft Market 2013-2023” offers the reader detailed analysis of the global commercial aircraft market over the next ten years, alongside potential market opportunities to enter the industry, using detailed market size forecasts. What are the key drivers behind recent market changes? The global commercial aircraft sector is expected to experience …
- Fuel Assemblies for Nuclear Power: – Global Market Size, Average Pricing, Competitive Landscape and Key Country Analysis to 2020Fuel Assemblies for Nuclear Power: - Global Market Size, Average Pricing, Competitive Landscape and Key Country Analysis to 2020 Summary GlobalData’s latest report "Fuel Assemblies for Nuclear Power: - Global Market Size, Average Pricing, Competitive Landscape and Key Country Analysis to 2020" analyzes the market for nuclear fuel assemblies used in commercial nuclear reactors and provides in-depth …
- ソフトスキルトレーニングの世界市場2015-2019About Soft Skills Soft skills can be broadly categorized into three: character, interpersonal skills, and critical and creative thinking. In both academic and corporate environment, effective soft skills play a crucial role in enabling individuals communicate effectively, manage relationships, lead a team, and solve problems. Therefore, apart from training students and employees in technical skill …
- モバイル・アナリティクスの世界市場2016-2020About the Mobile Analytics Market Mobile analytics is used to analyze the mobile website traffic like traditional analytics. It involves the use of data collected as visitors access a website from their mobile devices. It helps to determine which mobile marketing campaigns work best for the business and which aspects of the websites work best for the mobile traffic, including mobile search marketi …
